Sort
78,016 grants matching “breast cancer”
A systems-level approach to therapeutically target STING in cancer
$701,876Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
TARGETING ESR1 MUTANT BREAST CANCER
$701,872Sloan-Kettering Institute For Cancer Research · · FY2014 · Department of Defense
Nuclear receptors: action, functions, and roles in disease
$701,864Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
A new radiopharmaceutical for the treatment of metastatic bone cancer
$701,849Jaime Nmn Simon · Isotherapeutics Group, Llc · R44 · FY2014 · CA
Florida Hospital Cancer Institute Community Clinical Oncology Program
$701,835Lee Zehngebot · Adventhealth Orlando · U10 · FY2013 · CA
Cancer and Inflammation - Genetics and Function
$701,821Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
LEVERAGING SYSTEMATIC CHEMICAL-GENETIC PROFILING AS A PATH TO EXPAND PRECISION MEDICINE IN BREAST CANCER
$701,798Northwestern University · · FY2022 · Defense Health Agency
Evaluation of novel tomosynthesis density measures in breast cancer risk prediction
$701,775Celine M Vachon · Mayo Clinic Rochester · R01 · FY2023 · CA
Career Development in Pediatric and Medical Oncology
$701,719Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2017 · CA
EXERCISE, DIET, AND SEX HORMONES IN POSTMENOPAUSAL WOMEN
$701,672Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
Elucidating resistance mechanisms and enhancing response to immune checkpoint blockade in central nervous system metastases from breast cancer
$701,661Priscilla Kaliopi Brastianos · Massachusetts General Hospital · R01 · FY2025 · CA
Stress-activated signaling in prostate cancer
$701,622George A Kulik · Wake Forest University Health Sciences · R01 · FY2009 · CA
Systematic Light Exposure to treat Cancer-Related Fatigue in Breast Cancer Patients
$701,462William H Redd · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
$701,440Robert J Gray · Dana-Farber Cancer Inst · U01 · FY2018 · CA
NCI X-ray free electron laser (XFEL) initiative
$701,422Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Elucidating resistance mechanisms and enhancing response to immune checkpoint blockade in central nervous system metastases from breast cancer
$701,408Priscilla Kaliopi Brastianos · Massachusetts General Hospital · R01 · FY2024 · CA
Cancer Center Support Grant - Core Consolidation Supplement
$701,380Gerold Bepler · Wayne State University · P30 · FY2010 · CA
Surgical Treament for Early State Breast Cancer
$701,296University Of Michigan At Ann Arbor · R01 · FY2001 · CA
Hormonal Regulation of Breast Cancer
$701,251Jeffrey Rosen · Baylor College Of Medicine · R01 · FY2012 · CA
Early Screening of Breast Lesion Trial (Phase III Pivotal)
$701,169David A. Benaron · Spectros Corporation · R44 · FY2009 · CA
The NYU Women's Health Study
$701,162Anne Zeleniuch-Jacquotte · New York University School Of Medicine · UM1 · FY2018 · CA
A Randomized Trial to Minimize Non-Response to Aerobic Training in Operable Breast Cancer
$701,097Jessica Scott · Sloan-Kettering Inst Can Research · R37 · FY2021 · CA
A Randomized Trial to Minimize Non-Response to Aerobic Training in Operable Breast Cancer
$701,097Jessica Scott · Sloan-Kettering Inst Can Research · R37 · FY2022 · CA
Angiogenesis imaging
$701,062Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Energy Balance, mTOR pathway signaling, and breast cancer prognosis
$701,049Ting-Yuan Cheng · Ohio State University · R37 · FY2024 · CA